Domenico Maione

This inventor holds 11 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Glaxosmithkline Biologicals Sa, Novartis Ag, Novartis Vaccines & Diagnostics, Gmbh. Active years: 2012-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Domenico Maione. Retrieved from https://idiyas.com/inventor/domenico-maione

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 9)

% Patents Active = 72.7

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 9(Granted Patents)

Location History:

Castelnuovo Berardenga, IT (2015)
Siena, IT (2012 - 2019)

Company Filing History:

7 out of 545

Glaxosmithkline Biologicals Sa

Novartis Vaccines & Diagnostics, Gmbh

patents

4. 1 out of 47

Novartis Vaccines and Diagnostics Srl

patents

Years Active: 2012-2019

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10286055 - Immunogenic composition (2019-05-14),

2. 10245310 - Carrier molecule for antigens (2019-04-02),

3. 10086060 - Immunogenic proteins and compositions (2018-10-02),

4. 9855325 - Immunogenic composition (2018-01-02),

5. 9855324 - Immunogenic compositions (2018-01-02),

6. 9725488 - Immunogenic proteins and compositions (2017-08-08),

7. 9458229 - Immunogenic proteins and compositions (2016-10-04),

8. 9079946 - [object Object] (2015-07-14),

9. 8945589 - [object Object] (2015-02-03),

10. 8778358 - [object Object] (2014-07-15),

11. 8147849 - [object Object] (2012-04-03),

Title: Innovations and Contributions of Domenico Maione

Introduction

Domenico Maione is a prominent inventor based in Siena, Italy, known for his significant contributions to the field of immunology. With a total of 11 patents to his name, he has made remarkable advancements in the development of immunogenic compositions and carrier molecules for antigens.

Latest Patents

Among his latest patents, one notable invention is an immunogenic composition designed to raise an immune response in mammals. This composition comprises capsular saccharides from Group B Streptococcus (GBS) serotypes conjugated to carrier proteins. Another significant patent involves a conjugate that includes an antigen and a carrier molecule, specifically featuring BP-2a and spb1 antigens. This conjugate is intended for use in methods aimed at eliciting an immune response in mammals, with applications in pharmaceutical compositions, particularly vaccines.

Career Highlights

Domenico Maione has had a distinguished career, working with leading pharmaceutical companies such as GlaxoSmithKline Biologicals and Novartis AG. His work has focused on innovative solutions in vaccine development and immunotherapy, contributing to advancements in public health.

Collaborations

Throughout his career, Maione has collaborated with esteemed colleagues, including Guido Grandi and Cira Daniela Rinaudo. These partnerships have fostered a collaborative environment that has enhanced the research and development of immunological products.

Conclusion

Domenico Maione's contributions to immunology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence vaccine development and improve health outcomes.

Profile summary based on public USPTO records.